Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on July 23, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Gamma-Ray Spectrometry Software Suite

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract seeks the supply and integration of a specialized software suite designed for the acquisition, analysis, and reporting of gamma-ray spectra, with mandatory compatibility with both the Genie 2000/APEX platform and the FDA’s WEAC software environment. The solution must seamlessly interface with existing federal systems to ensure consistent data handling, calibration, and spectral interpretation across operational workflows. The software will support critical measurement tasks within a regulated environment, requiring high accuracy, auditability, and compliance with established FDA protocols for radiation detection and nuclear material identification. The contract is classified as a subcontract under NAICS code 511210 and is issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. Performance is required to be conducted at a designated location in Winchester, Massachusetts, with a ZIP code of 01890. The solicitation was posted on July 23, 2026, and responses must be submitted by August 7, 2026, at 5:00 PM Eastern Time. There is no set-aside designation, and while no point of contact is listed, the solicitation is accessible through the SAM.gov portal for interested parties seeking further details or submission instructions.

General Info

Supply and integrate gamma-ray software compatible with Genie 2000/APEX and FDA WEAC, compliant, in Winchester, MA.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

511210 - Software PublishersView NAICS

Place of Performance

Winchester, MA, 01890, USA

Set-Aside

NONE

Documents

This scope was carved out of FDA-75F40126Q00304.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

High Purity Germanium Gamma-Ray Spectrometer

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply and integration of software for acquisition, analysis, and reporting of gamma-ray spectra, compatible with genie 2000/APEX and FDA’s WEAC software environment.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 21 hours ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS